Newsroom | 5263 results

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc, a leader in AI-powered health technology focused on complex conditions, today announced that it is officially live as an approved Participant in the Centers for Medicare & Medicaid Services (CMS) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. As a credentialed Medicare Part B supplier, Welldoc joins the first cohort of digital health solutions going live with the CMS July 5 launch. Eligible beneficiaries navigating traditio...

NORTH BETHESDA, Md.--(BUSINESS WIRE)--The Foundation for the National Institutes of Health awards the 2026 Montrone-Seigel Prize in Biomedical Sciences to Shingo Kajimura, PhD....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc. (www.TIXiMED.com), a clinical-stage pharmaceutical company developing a novel disease-modifying oral therapy for type 1 diabetes (T1D), today announced the initiation of the Phase 1b Multiple Ascending Dose (MAD) study of TIX100 (NCT07675590), an investigational oral inhibitor of thioredoxin-interacting protein (TXNIP). The TIX100 MAD study is a double-blind, randomized, placebo-controlled trial evaluating the safety, tolerability, and pharmacoki...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Accelerates Global Growth with Launch of Omnipod 5 and Omnipod Discover in Spain, Expanding Access to Tubeless Diabetes Technology...

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through a network of authorized distribution partners. Brazil is the largest medical device market in Latin America and one of the fastest-growing ultrasound markets globally,1,...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial....

SAN DIEGO--(BUSINESS WIRE)--The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in five EU countries....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time). The link to the live call will be available on the I...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after the financial markets close on Thursday, August 6, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2026 financial and operating results.A live webcast of the call will be available on Tandem Diabet...

LOS ANGELES--(BUSINESS WIRE)--Die AIDS Healthcare Foundation (AHF) begrüßte das Engagement der Mitgliedstaaten auf der hochrangigen Konferenz der Vereinten Nationen zum Thema HIV/AIDS, unterstrich jedoch gleichzeitig, dass Millionen von Menschen, die mit HIV leben, noch immer keinen Zugang zu lebensrettender Behandlung haben und dass schätzungsweise 1,2 Millionen Menschen jedes Jahr an HIV erkranken. Während Regierungen ihr Engagement für die Beseitigung von AIDS als Bedrohung der öffentlichen...